B

Kamada Ltd. KMDA

$7.74 -$0.09-1.15% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.71$7.97
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

KMDA Rating

Reward
Risk

KMDA Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

KMDA Company Overview

Kamada Ltd. is an Israel-based biopharmaceutical company focused on specialty plasma-derived therapeutics, with operations spanning the development, manufacture, and commercialization of products targeting rare and serious medical conditions. The company primarily operates in the biotechnology and specialty pharmaceuticals industries, with a business model centered on proprietary plasma-derived protein therapeutics, contract manufacturing services, and plasma collection activities. Kamada’s revenue is generated through sales of commercial products, distribution partnerships, technology licensing, and manufacturing agreements. Its flagship commercial product portfolio has historically included therapies for alpha-1 antitrypsin deficiency, rabies post-exposure prophylaxis, and immune globulin products.

The company serves hospitals, specialty clinics, government healthcare systems, and pharmaceutical partners across multiple international markets. Kamada has developed strategic positioning through vertically integrated plasma collection and manufacturing capabilities, long-term distribution collaborations, and expertise in plasma-derived biologics production. Founded in 1990 in Israel, the company evolved from a niche plasma therapeutics developer into a diversified specialty biopharmaceutical organization with both proprietary products and contract development and manufacturing operations. Over time, Kamada expanded its commercial footprint through acquisitions, plasma collection investments, and partnerships with larger pharmaceutical distributors.

Data compiled by narrative technology. May contain errors.
Sector

KMDA Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

KMDA Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

KMDA Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

KMDA Price History

Loading...
52-Week Range42% of range
Current
$7.74
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

KMDA Valuation

Market Cap
Market Cap Rank
#8,094
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

KMDA Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

KMDA Corporate Info

Phone Number
972 8 940 6472
Address
2 Holzman Street
Science Park
PO Box 4081
Rehovot, 7670402
Country
Year Founded

KMDA Filings

Filing Date
Monday, November 9, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Mar 8 and 12 (est)

KMDA Headlines

11/9/2026 - Seeking Alpha - Israel Stocks
11/9/2026 - Zacks Investment Research